Liebelson family office

Liebelson Family Office is a private investment firm that manages the capital of the Liebelson family, with a primary focus on venture capital investments in the life sciences and biotechnology sectors. The firm actively supports early-to-late-stage companies developing innovative therapeutic platforms, including gene therapies, cell therapies, and synthetic biology. Notable investments in their portfolio include Senti Bio, Lexeo Therapeutics, Kallyope, and Tessera Therapeutics. Based in the United States, the office provides strategic capital and maintains a network of co-investors among top-tier biotech venture capital firms. The firm targets breakthrough medical research and clinical programs that have the potential to address significant unmet medical needs.